PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 105 participants.
Also called NCT03970538
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 105 participants
- Sponsor
- LimFlow, Inc.
- Registry
-
NCT03970538
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Puerto Rico
- Registry status
- Unknown status
Technical summary
Registry record NCT03970538. Allocation not applicable; no masking; primary purpose treatment. Start 2019-12-06 (actual); primary completion 2022-09-09 (actual). Results posted on 2024-02-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Acronym
- PROMISE
- Condition
- Critical Limb Ischemia
- Condition
- Critical Lower Limb Ischemia
- Condition
- Peripheral Artery Disease
- Condition
- Peripheral Arterial Disease
- Condition
- Chronic Limb-Threatening Ischemia
- Condition
- Arterial Occlusive Diseases
- Condition
- Arterial Occlusion
- Condition
- Arterial Disease
- Condition
- Peripheral Artery Occlusion
- Condition
- Peripheral Vascular Disease
- Condition
- Peripheral Ischemia
- Condition
- Vascular Diseases
- Intervention (Device)
- LimFlow System
- Lead sponsor
- LimFlow, Inc.
Record details
- Record id
cardio:ct-nct03970538- Content hash
0e44474daa5d4a78f7c88689b2edbc51a79b056db3535bb4f5b3747ffe8edcfe